Characteristics and Management of Sclerosing Skin Diseases Arising During Immune Checkpoint Inhibitor Therapy: An Evidence-Based Review

Description

Immune checkpoint inhibitors (ICI) are well-established for use in several cancers such as melanoma. Nonetheless, recent literature has increasingly described the onset of sclerosing skin disease (SSDs) during ICI therapy. This systematic review examines evidence regarding this phenomenon.

Categories

Licence